A possible mechanism underlying an antidepressive-like effect of kososan, a kampo medicine, via the hypothalamic orexinergic system in the stress-induced depression-like model mice

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 10, 2009, Pages 1716-1722

  Ito, Naoki ^a   Yabe, Takeshi ^a   Nagai, Takayuki ^a   Oikawa, Tetsuro ^a   Yamada, Haruki ^a   Hanawa, Toshihiko ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Antidepressive like effect; Cell proliferation; Kampo; Kososan; Neuropeptide Y; Orexin A

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; ANTIDEPRESSANT AGENT; BROXURIDINE; CORTICOSTERONE; KAMPO; KOSOSAN; MILNACIPRAN; NEUROPEPTIDE Y; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DENTATE GYRUS; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; HYPOTHALAMUS; IMMOBILIZATION STRESS; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MOUSE; NONHUMAN; STRESS;

ANGIOSPERMS; ANIMALS; BROMODEOXYURIDINE; CELL PROLIFERATION; CYCLOPROPANES; DEPRESSION; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; HIPPOCAMPUS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEDICINE, KAMPO; MICE; MICE, INBRED STRAINS; NEUROPEPTIDE Y; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PHYTOTHERAPY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL;

EID: 70350017969     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1716     Document Type: Article

References (45)

1. Hanawa T., Journal of Kampo Medicine, 42, 418-426 (1995).
2. Ito N., Nagai T., Yabe T., Nunome S., Hanawa T., Yamada H., Phytomedicine, 13, 658-667 (2006).
3. Nagai T., Narikawa T., Ito N., Takeda T., Hanawa T., Yamada H., J. Trad. Med., 25, 74-80 (2008).
4. Holsboer F., Neuropsychopharmacology, 23, 477-501 (2000).
5. Kendler K. S., Karkowski L. M., Prescott C. A., Am. J. Psychiatry, 156, 837-841 (1999).
6. Holsboer F., Barden N., Endocr. Rev., 17, 187-205 (1996).
7. Joels M., Karst H., Alfarez D., Heine V. M., Qin Y., van Riel E., Verkuyl M., Lucassen P. J., Krugers H. J., Stress, 7, 221-231 (2004).
8. Gold P. W., Chrousos G. P., Mol. Psychiatry, 7, 254-275 (2002).
9. Duman R. S., Malberg J., Thome J., Biol. Psychiatry, 46, 1181-1191 (1999).
10. Tanapat P., Galea L. A., Gould E., Int. J. Dev. Neurosci., 16, 235-239 (1998).
11. Malberg J. E., Eisch A. J., Nestler E. J., Duman R. S., J. Neurosci., 20, 9104-9110 (2000).
12. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., Hen R., Science, 301, 805-809 (2003).
13. Peyron C., Tighe D. K., van den Pol A. N., de Lecea L., Heller H. C., Sutcliffe J. G., Kilduff T. S., J. Neurosci., 18, 9996-10015 (1998).
14. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K., Brain Res., 827, 243-260 (1999).
15. Allard J. S., Tizabi Y., Shaffery J. P., Trouth C. O., Manaye K., Neuropeptides, 38, 311-315 (2004).
16. Brundin L., Bjorkqvist M., Petersen A., Traskman-Bendz L., Eur. Neuropsychopharmacol., 17, 573-579 (2007).
17. Ito N., Yabe T., Gamo Y., Nagai T., Oikawa T., Yamada H., Hanawa T., Neuroscience, 157, 720-732 (2008).
18. Hervieu G. J., Cluderay J. E., Harrison D. C., Roberts J. C., Leslie R. A., Neuroscience, 103, 777-797 (2001).
19. Clark J. T., Kalra P. S., Kalra S. P., Endocrinology, 117, 2435-2442 (1985).
20. Kharlamov E. A., Kharlamov A., Kelly K. M., Brain Res., 1127, 151-162 (2007).
21. Widerlov E., Lindstrom L. H., Wahlestedt C., Ekman R., J. Psychiatr. Res., 22, 69-79 (1988).
22. Gjerris A., Widerlov E., Werdelin L., Ekman R., J. Psychiatry Neurosci., 17, 23-27 (1992).
23. Heilig M., Zachrisson O., Thorsell A., Ehnvall A., Mottagui-Tabar S., Sjogren M., Asberg M., Ekman R., Wahlestedt C., Agren H., J. Psychiatr. Res., 38, 113-121 (2004).
24. Redrobe J. P., Dumont Y., Fournier A., Quirion R., Neuropsychopharmacology, 26, 615-624 (2002).
25. Howell O. W., Scharfman H. E., Herzog H., Sundstrom L. E., Beck-Sickinger A., Gray W. P., J. Neurochem., 86, 646-659 (2003).
26. Zhang Y. Z., Li Y. F., Yu N. J., Yuan L., Zhao Y. M., Xiao W. B., Luo Z. P., Chin. Med. J. (Engl), 120, 1792-1796 (2007).
27. An L., Zhang Y. Z., Yu N. J., Liu X. M., Zhao N., Yuan L., Chen H. X., Li Y. F., Prog. Neuropsychopharmacol. Biol. Psychiatry, 32, 1484-1490 (2008).
28. Porsolt R. D., Bertin A., Jalfre M., Arch. Int. Pharmacodyn. Ther., 229, 327-336 (1977).
29. Detke M. J., Johnson J., Lucki I., Exp. Clin. Psychopharmacol., 5, 107-112 (1997).
30. Solberg L. C., Horton T. H., Turek F. W., Am. J. Physiol., 276, R152-161 (1999).
31. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R., Psychopharmacology (Berlin), 93, 358-364 (1987).
32. Wong M. L., Licinio J., Nat. Rev. Neurosci., 2, 343-351 (2001).
33. Lee H. J., Kim J. W., Yim S. V., Kim M. J., Kim S. A., Kim Y. J., Kim C. J., Chung J. H., Mol. Psychiatry, 6, 610, 725-1618 (2001).
34. Alonso R., Griebel G., Pavone G., Stemmelin J., Le Fur G., Soubrie P., Mol. Psychiatry, 9, 278-286, 224 (2004).
35. Li Y. F., Zhang Y. Z., Liu Y. Q., Wang H. L., Yuan L., Luo Z. P., Acta Pharmacol. Sin., 25, 1408-1412 (2004).
36. Cameron H. A., Gould E., Neuroscience, 61, 203-209 (1994).
37. Muroya S., Funahashi H., Yamanaka A., Kohno D., Uramura K., Nambu T., Shibahara M., Kuramochi M., Takigawa M., Yanagisawa M., Sakurai T., Shioda S., Yada T., Eur. J. Neurosci., 19, 1524-1534 (2004).
38. Ishida H., Shirayama Y., Iwata M., Kawahara R., Brain Res., 1046, 239-243 (2005).
39. Jimenez-Vasquez P. A., Mathe A. A., Thomas J. D., Riley E. P., Ehlers C. L., Brain Res. Dev. Brain Res., 131, 149-152 (2001).
40. Jimenez-Vasquez P. A., Diaz-Cabiale Z., Caberlotto L., Bellido I., Overstreet D., Fuxe K., Mathe A. A., Eur. Neuropsychopharmacol., 17, 298-308 (2007).
41. Hansel D. E., Eipper B. A., Ronnett G. V., Nature (London), 410, 940-944 (2001).
42. Howell O. W., Doyle K., Goodman J. H., Scharfman H. E., Herzog H., Pringle A., Beck-Sickinger A. G., Gray W. P., J. Neurochem., 93, 560-570 (2005).
43. Howell O. W., Silva S., Scharfman H. E., Sosunov A. A., Zaben M., Shatya A., McKhann G., 2nd, Herzog H., Laskowski A., Gray W. P., Neurobiol. Dis., 26, 174-188 (2007).
44. Ishida H., Shirayama Y., Iwata M., Katayama S., Yamamoto A., Kawahara R., Nakagome K., Hippocampus, 17, 271-280 (2007).
45. Karlsson R. M., Choe J. S., Cameron H. A., Thorsell A., Crawley J. N., Holmes A., Heilig M., Psychopharmacology (Berlin), 195, 547-557 (2008).